Efficacy and safety of Chaihu Guizhi Ganjiang Tang for type 2 diabetes: systematic review and meta-analysis

30-Second Summary

This systematic review and meta-analysis of 12 trials (883 patients) suggests that adding Chaihu Guizhi Ganjiang Tang to conventional therapy improves glycemic control (reductions in HbA1c, FPG, 2hPG), decreases insulin resistance, improves beta‑cell function, and benefits lipid profiles with fewer short‑term adverse events. Evidence quality was low to moderate, so larger, higher‑quality and longer‑term trials are needed to confirm efficacy and safety.

1-Minute Summary

3-Minute Summary

Full Analysis

Health Implications

Key Findings